Release Date: 06/10/20 12:27 Summary: Change of Director's Interest Notice - Andrew Monk Price Sensitive: No Download Document 568.84KB Download
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling